These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 23352311

  • 21. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S, Krauze-Brzósko K, Manarini S, Evangelista V, Cerletti C.
    Eur J Pharmacol; 2004 Mar 19; 488(1-3):79-83. PubMed ID: 15044038
    [Abstract] [Full Text] [Related]

  • 22. Evidence for a role in thrombus stabilization for thromboxane A2 in human platelet deposition on collagen.
    Wagner WR, Hubbell JA.
    J Lab Clin Med; 1992 Jun 19; 119(6):690-7. PubMed ID: 1534345
    [Abstract] [Full Text] [Related]

  • 23. Statins have an early antiplatelet effect in patients with acute myocardial infarction.
    Matetzky S, Fefer P, Shenkman B, Shechter M, Novikov I, Savion N, Varon D, Hod H.
    Platelets; 2011 Jun 19; 22(2):103-10. PubMed ID: 21171935
    [Abstract] [Full Text] [Related]

  • 24. Multiple antiplatelet effects of clopidogrel are not modulated by statin type in patients undergoing percutaneous coronary intervention.
    Smith SM, Judge HM, Peters G, Storey RF.
    Platelets; 2004 Dec 19; 15(8):465-74. PubMed ID: 15763887
    [Abstract] [Full Text] [Related]

  • 25. Effects of statins on biomarkers of bone metabolism: a randomised trial.
    Stein EA, Farnier M, Waldstreicher J, Mercuri M, Simvastatin/Atorvastatin Study Group.
    Nutr Metab Cardiovasc Dis; 2001 Apr 19; 11(2):84-7. PubMed ID: 11434192
    [Abstract] [Full Text] [Related]

  • 26. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease.
    Sciulli MG, Renda G, Capone ML, Tacconelli S, Ricciotti E, Manarini S, Evangelista V, Rebuzzi A, Patrignani P.
    Clin Pharmacol Ther; 2006 Aug 19; 80(2):115-25. PubMed ID: 16890573
    [Abstract] [Full Text] [Related]

  • 27. Failure of aspirin to impair bovine platelet function.
    Gentry PA, Tremblay RR, Ross ML.
    Am J Vet Res; 1989 Jun 19; 50(6):919-22. PubMed ID: 2764343
    [Abstract] [Full Text] [Related]

  • 28. Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization.
    Jin YR, Cho MR, Ryu CK, Chung JH, Yuk DY, Hong JT, Lee KS, Lee JJ, Lee MY, Lim Y, Yun YP.
    J Pharmacol Exp Ther; 2005 Jan 19; 312(1):214-9. PubMed ID: 15328379
    [Abstract] [Full Text] [Related]

  • 29. De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin.
    Evangelista V, Manarini S, Di Santo A, Capone ML, Ricciotti E, Di Francesco L, Tacconelli S, Sacchetti A, D'Angelo S, Scilimati A, Sciulli MG, Patrignani P.
    Circ Res; 2006 Mar 17; 98(5):593-5. PubMed ID: 16484611
    [Abstract] [Full Text] [Related]

  • 30. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC, Wang TW, Wang WY, Hsieh PW, Wu YC.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):37-43. PubMed ID: 16313903
    [Abstract] [Full Text] [Related]

  • 31. Statin-stimulated nitric oxide release from endothelium.
    Dobrucki LW, Kalinowski L, Dobrucki IT, Malinski T.
    Med Sci Monit; 2001 Dec 19; 7(4):622-7. PubMed ID: 11433186
    [Abstract] [Full Text] [Related]

  • 32. The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes.
    Mitsios JV, Papathanasiou AI, Elisaf M, Goudevenos JA, Tselepis AD.
    Platelets; 2005 Aug 19; 16(5):287-92. PubMed ID: 16011979
    [Abstract] [Full Text] [Related]

  • 33. Distinct effects of pravastatin, atorvastatin, and simvastatin on insulin secretion from a beta-cell line, MIN6 cells.
    Ishikawa M, Okajima F, Inoue N, Motomura K, Kato T, Takahashi A, Oikawa S, Yamada N, Shimano H.
    J Atheroscler Thromb; 2006 Dec 19; 13(6):329-35. PubMed ID: 17192698
    [Abstract] [Full Text] [Related]

  • 34. Effect of pravastatin, simvastatin and atorvastatin on the phagocytic activity of mouse peritoneal macrophages.
    Djaldetti M, Salman H, Bergman M, Bessler H.
    Exp Mol Pathol; 2006 Apr 19; 80(2):160-4. PubMed ID: 16269144
    [Abstract] [Full Text] [Related]

  • 35. Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment.
    Malmström RE, Ostergren J, Jørgensen L, Hjemdahl P, CASTOR investigators.
    J Intern Med; 2009 Nov 19; 266(5):457-66. PubMed ID: 19549094
    [Abstract] [Full Text] [Related]

  • 36. Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis.
    Wenaweser P, Windecker S, Billinger M, Cook S, Togni M, Meier B, Haeberli A, Hess OM.
    Am J Cardiol; 2007 Feb 01; 99(3):353-6. PubMed ID: 17261397
    [Abstract] [Full Text] [Related]

  • 37. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
    Lee JJ, Jin YR, Lim Y, Hong JT, Kim TJ, Chung JH, Yun YP.
    Vascul Pharmacol; 2006 Sep 01; 45(3):148-53. PubMed ID: 16916624
    [Abstract] [Full Text] [Related]

  • 38. Redox markers and inflammation are differentially affected by atorvastatin, pravastatin or simvastatin administered before endotoxin-induced acute lung injury.
    Melo AC, Valença SS, Gitirana LB, Santos JC, Ribeiro ML, Machado MN, Magalhães CB, Zin WA, Porto LC.
    Int Immunopharmacol; 2013 Sep 01; 17(1):57-64. PubMed ID: 23747588
    [Abstract] [Full Text] [Related]

  • 39. Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells.
    Izidoro-Toledo TC, Guimaraes DA, Belo VA, Gerlach RF, Tanus-Santos JE.
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Jun 01; 383(6):547-54. PubMed ID: 21448567
    [Abstract] [Full Text] [Related]

  • 40. TXA2 synthesis and COX1-independent platelet reactivity in aspirin-treated patients soon after acute cerebral stroke or transient ischaemic attack.
    Valles J, Lago A, Moscardo A, Tembl J, Parkhutik V, Santos MT.
    Thromb Res; 2013 Aug 01; 132(2):211-6. PubMed ID: 23830213
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.